Diabetes: Page 5


  • A person smiles while wearing a square device on their hip and a round device on their upper arm.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Medicare adviser sets recommendations for diabetes device evidence

     A MEDCAC panel found time in range was an “extremely important” metric, but members were divided on whether quality of life measures should influence coverage.

    By May 22, 2024
  • A person playing pickleball wears a circular patch on their upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom details plans for over-the-counter CGM as insulin pump firms seek Type 2 coverage

    Diabetes tech companies shared updates on new products, largely focused on Type 2 patients, in Q1 earnings calls.

    By May 16, 2024
  • Overhead view of brick, multistory buildings along a one-way street.
    Image attribution tooltip
    deberarr via Getty Images
    Image attribution tooltip

    FDA targets health inequality by improving at-home devices

    Michelle Tarver, an FDA official, said a new program is meant to advance health equity by considering people’s living conditions as part of medical device design.

    By May 13, 2024
  • A person smiles while wearing a square device on their hip and a round device on their upper arm.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem reports 224 injuries related to faulty insulin pump app

    A problem with Tandem’s iPhone app could drain the battery of the connected insulin pump, causing it to power down sooner than expected.

    By May 9, 2024
  • A cylindrical device on the left with a wifi signal, next to a black rounded device and a smartphone showing a blood glucose reading.
    Image attribution tooltip
    Permission granted by Senseonics
    Image attribution tooltip

    Senseonics gets FDA clearance to pair CGM implant with insulin pumps

    Analysts said the designation and planned one-year sensor could help Senseonics’ device appeal to more patients.

    By May 1, 2024
  • A picture of the lobby of Boston Scientific's corporate China reception.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific, Dexcom and Edwards next as earnings season rolls on

    J.P. Morgan analysts expect this week’s results to be “very good” following reports from J&J, Abbott and Intuitive Surgical.

    By April 23, 2024
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet names Ana Maria Chadwick CFO

    Chadwick succeeds Wayde McMillan, who left last year to become CFO for 3M’s health spinoff.

    By March 21, 2024
  • A picture of Sequel's Twiist automated insulin delivery system.
    Image attribution tooltip
    Courtesy of Sequel Med Tech
    Image attribution tooltip

    Deka’s automated insulin delivery system, powered by patient-led app, gets FDA clearance

    Sequel Med Tech will sell the new system, which integrates with Tidepool’s Loop insulin dosing algorithm.

    By March 20, 2024
  • Header image for "77% of Companies Are Currently Undertaking or Considering Layoffs"
    Image attribution tooltip
    Getty Images via Getty Images
    Image attribution tooltip

    Better Therapeutics lays off staff, considers winding down business

    The digital therapeutics developer received authorization for a Type 2 diabetes treatment app last year but has struggled for money.

    By March 15, 2024
  • A person playing pickleball wears a circular patch on their upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom’s over-the-counter nod sets stage for broader CGM use

    The FDA’s decision allows people who don’t take insulin, including those who don’t have diabetes, to use the devices without a prescription.

    By March 7, 2024
  • A Roche logo is seen on the side of a building.
    Image attribution tooltip
    Courtesy of Roche
    Image attribution tooltip

    Roche to take on Abbott, Dexcom with its first CGM

    The new sensor is designed to last for 14 days but requires finger-stick calibration.

    By March 7, 2024
  • Nick Jonas, Dexcom
    Image attribution tooltip
    Courtesy of Dexcom, Nick Jonas Super Bowl kit
    Image attribution tooltip

    Dexcom receives FDA clearance for first OTC glucose sensor

    The diabetes tech firm is tailoring its software to the 25 million people in the U.S. who have Type 2 diabetes and do not use insulin.

    By March 6, 2024
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom, Novo Nordisk call for FDA input on digital diabetes detection devices

    The companies want clarity on what evidence would be needed for new technologies to detect undiagnosed Type 2 diabetes or prediabetes.

    By March 4, 2024
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet sizes up competition as Tandem, Medtronic plan new insulin patch-pumps

    Insulet CEO Jim Hollingshead said the company is “very confident” in its competitive position as rivals develop their own patch pumps.

    By Feb. 29, 2024
  • the FDA Headquarters
    Image attribution tooltip
    Sara Silbiger via Getty Images
    Image attribution tooltip

    FDA warns against using smart wearables that claim to measure blood sugar

    Unauthorized smartwatches and smart rings are “manufactured by dozens of companies and sold under multiple brand names,” according to the agency.

    By Feb. 23, 2024
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet wins CE mark for integration of insulin pump with Abbott CGM

    The clearance positions Insulet to sell the integrated Type 1 diabetes product in Europe beginning in the first half of the year.

    By Feb. 8, 2024
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA extends deadline for comments on role of digital health in diabetes detection

    The agency is seeking answers on how digital health technologies could be used in the detection of prediabetes and Type 2 diabetes.

    By Jan. 31, 2024
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott says all four segments stronger than pre-pandemic

    CEO Robert Ford said investing in its base business using COVID-19 testing revenues was “absolutely the right strategy.”

    By Jan. 24, 2024
  • Signs for Johnson & Johnson are seen on company offices in California.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    3 bellwether companies to watch as medtech earnings season begins

    J&J, Intuitive Surgical and Abbott kick off this week with fourth-quarter reports.

    By Jan. 22, 2024
  • A smartphone screen reads "Your glucose is steady. Grab a leafy green snack to maintain momentum."
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott CEO talks diabetes market, device pricing at J.P. Morgan conference

    CEO Robert Ford is “very confident” in Abbott’s ability to pass $10 billion in sales of its Libre continuous glucose monitor products by 2028.

    By Jan. 10, 2024
  • Professional photo of Geoff Martha
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic focused on delivering durable revenue and profit growth

    “Our top priority is restoring our earnings power, full stop,” CEO Geoff Martha said Monday at the J.P. Morgan Healthcare Conference.

    By Jan. 9, 2024
  • Professional photo of Kevin Sayer
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom plans to launch new CGM this summer for people who don’t take insulin

    The company also shared earnings expectations for 2024 at the J.P. Morgan Healthcare Conference.

    By Jan. 9, 2024
  • A person smiles while wearing a square device on their hip and a round device on their upper arm.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Abbott, Tandem launch new hybrid closed-loop insulin delivery system

    Competitor Medtronic also received a CE mark for a new CGM sensor that can integrate with its 780G pump.

    By Jan. 8, 2024
  • An embpty bed is surrounded by monitors and hospital equipment.
    Image attribution tooltip
    Martin Barraud via Getty Images
    Image attribution tooltip

    BTIG analysts optimistic medtech will rebound in 2024 after ‘string of rough years’

    Rising interest rates, fears about the impact of GLP-1 drugs and “choppy supply-chain dynamics” dragged on the industry this year, the analysts wrote.

    By Dec. 18, 2023
  • A person types on a computer with a stethoscope in the background.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem completes US launch of revamped diabetes management platform

    The platform, Tandem Source, combines the features of the company’s legacy t:connect offerings with new data reports.

    By Dec. 15, 2023